Literature DB >> 8425581

Reversibility of exogenous corticosteroid-induced bone loss.

G Rizzato1, L Montemurro.   

Abstract

Osteoporosis is not usually considered to be reversible, as it is a consequence of the ageing process. However, an improvement of bone mineral density after successful surgery in Cushing's syndrome has been shown in several reports. The question of reversibility of exogenous corticosteroid-induced osteoporosis is, as yet, unanswered, possibly because of the difficulty in discontinuing steroids after long-term use. We describe six patients, all under 45 yrs of age, with chronic long-standing sarcoidosis, in whom long-term prednisone therapy resulted in 15 +/- 7% bone loss, as evaluated by quantitative computed tomography. This side-effect appeared fully reversible after prednisone withdrawal. This report of the reversibility of exogenous corticosteroid-induced bone loss needs confirmation in elderly people, where the capacity for recovery of bone mass could be reduced. Such potential for recovery may have implications for the pattern of use of corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425581

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

Review 1.  Clinical impact of bone and calcium metabolism changes in sarcoidosis.

Authors:  G Rizzato
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

2.  Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma.

Authors:  A F Wisniewski; S A Lewis; D J Green; W Maslanka; H Burrell; A E Tattersfield
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

Review 3.  Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.

Authors:  Albrecht W Popp; Juerg Isenegger; Elizabeth M Buergi; Ulrich Buergi; Kurt Lippuner
Journal:  Eur Spine J       Date:  2006-07       Impact factor: 3.134

4.  Goldilocks, vitamin D and sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

5.  Bone fragility in sarcoidosis and relationships with calcium metabolism disorders: a cross sectional study on 142 patients.

Authors:  Nathalie Saidenberg-Kermanac'h; Luca Semerano; Hilario Nunes; Danielle Sadoun; Xavier Guillot; Marouane Boubaya; Nicolas Naggara; Dominique Valeyre; Marie-Christophe Boissier
Journal:  Arthritis Res Ther       Date:  2014-03-24       Impact factor: 5.156

6.  Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.

Authors:  S Bours; F de Vries; J P W van den Bergh; A Lalmohamed; T P van Staa; H G M Leufkens; P P P Geusens; M Drent; N C Harvey
Journal:  Osteoporos Int       Date:  2015-12-02       Impact factor: 4.507

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.